Pulsatile GnRH Pump Therapy Leads to Ovulation and Pregnancy in a Patient with Polycystic Ovary Syndrome: A Case Study
-
By
-
Shumin Wang
-
Ying Xiong
-
Lang Qin
-
Kehui Xu
-
Meng Cheng
-
April 29, 2026
-
Clinical Scorecard: Pulsatile GnRH Pump Therapy Leads to Ovulation and Pregnancy in a Patient with Polycystic Ovary Syndrome: A Case Study
At a Glance
| Category | Detail |
|---|
| Condition | Polycystic Ovary Syndrome (PCOS) |
| Key Mechanisms | Dysregulation of the hypothalamic-pituitary-ovarian (HPO) axis affecting FSH and LH secretion. |
| Target Population | Women of reproductive age with PCOS and anovulatory infertility. |
| Care Setting | Clinical management of infertility in reproductive health. |
Key Highlights
- Pulsatile GnRH pump therapy led to successful ovulation and pregnancy in a PCOS patient.
- Patient previously failed conventional treatments including letrozole and HMG.
- No adverse effects such as ovarian hyperstimulation syndrome (OHSS) were reported.
Guideline-Based Recommendations
Diagnosis
- Diagnosis of PCOS based on Rotterdam criteria and exclusion of other endocrine disorders.
Management
- Consider pulsatile GnRH pump therapy for patients resistant to standard ovulation induction therapies.
Monitoring & Follow-up
- Regular monitoring of hormone levels and follicular development during treatment.
Risks
- Conventional therapies may lead to OHSS and multiple pregnancies.
Patient & Prescribing Data
Lean PCOS patients with normal LH levels.
Pulsatile GnRH therapy may be a viable alternative for patients with drug resistance.
Clinical Best Practices
- Utilize the 2023 International Evidence-Based Guidelines for PCOS diagnosis and management.
- Assess individual patient profiles to tailor ovulation induction strategies.
References
